VSee Health (VSEE) Stock Price, News & Analysis

Company Overview

VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.

In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes. These monitoring devices and connected health kits can be paired with the platform’s mobile and desktop applications, helping care teams track chronic conditions and intervene early when necessary. VSee also offers telemedicine APIs and white-label options, allowing healthcare organizations to customize the user experience and incorporate virtual care into existing workflows.

Founded in 2008 and headquartered in Mountain View, California, VSee Health serves a diverse array of clients, including hospitals, clinics, government agencies and non-profit organizations. The company’s technology has been used in settings ranging from rural and underserved communities to international disaster relief efforts. Under the leadership of founder and CEO Milton Chen, VSee Health has focused on expanding its global footprint and enhancing its platform’s scalability.

Key Stats

• Today's Range: $0.17 to $0.19
• 50-Day Range: $0.18 to $0.38
• 52-Week Range: $0.17 to $2.52
• Volume: 385,825 shs
• Average Volume: 657,797 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

VSee Health Stock Analysis - MarketRank™

VSee Health scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

VSee Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

VSee Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of VSee Health is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of VSee Health is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

VSee Health has a short interest ratio ("days to cover") of 0.93, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in VSee Health has recently decreased by 22.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

VSee Health does not currently pay a dividend.

Dividend Growth

VSee Health does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

4 people have searched for VSEE on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, VSee Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

19.72% of the stock of VSee Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

1.01% of the stock of VSee Health is held by institutions.

VSEE Stock Analysis - Frequently Asked Questions

How have VSEE shares performed this year?

VSee Health's stock was trading at $0.3744 on January 1st, 2026. Since then, VSEE shares have decreased by 51.1% and is now trading at $0.1829.

How were VSee Health's earnings last quarter?

VSee Health, Inc. (NASDAQ:VSEE) issued its quarterly earnings data on Tuesday, March, 31st. The company reported ($0.31) earnings per share for the quarter. The company earned $3.93 million during the quarter.

How do I buy shares of VSee Health?

Shares of VSEE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of VSee Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that VSee Health investors own include Bright Minds Biosciences (DRUG), Blink Charging (BLNK), Blade Air Mobility (BLDE), Archer Aviation (ACHR), Joby Aviation (JOBY), Lynas Rare Earths (LYSDY).

Company Calendar

• Last Earnings: 3/31/2026
• Today: 5/06/2026
• Next Earnings (Estimated): 6/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: INTERNET SOFTWARE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:VSEE
• Previous Symbol: NASDAQ:VSEE
• CIK: 1864531
• Web: N/A
• Phone: (561) 672-7068
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.73)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.71 million
• Net Margins: -100.64%
• Pretax Margin: -100.18%
• Return on Equity: N/A
• Return on Assets: -66.21%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 0.51
• Quick Ratio: 0.51

Sales & Book Value

• Annual Sales: $14.62 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.01) per share
• Price / Book: -17.60

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A